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Solitary Pulmonary Nodule on Helical
Dynamic CT Scans: Analysis of the
Enhancement Patterns Using a
Computer-Aided Diagnosis (CAD) System
Objective: We wanted to investigate the usefulness of a computer-aided diag-
nosis (CAD) system in assisting radiologists to diagnosis malignant solitary pul-
monary nodules (SPNs), as compared with diagnosing SPNs with using direct
personal drawing.
Materials and Methods: Forty patients with SPNs were analyzed. After the
pre-contrast scan was performed, an additional ten series of post-contrast
images were obtained at 20-second intervals. Two investigators measured the
attenuation values of the SPNs: a radiologist who drew the regions of interest
(ROIs), and a technician who used a CAD system. The Bland and Altman plots
were used to compare the net enhancement between a CAD system and direct
personal drawing. The diagnostic characteristics of the malignant SPNs were cal-
culated by considering the CAD and direct personal drawing and with using
Fisher’s exact test.
Results: On the Bland and Altman plot, the net enhancement difference
between the CAD system and direct personal drawing was not significant (within
± 2 standard deriation). The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and accuracy of diagnosing malignant
SPNs using CAD was 92%, 85%, 75%, 96% and 88%, respectively. The sensitiv-
ity, specificity, PPV, NPV and accuracy of diagnosing malignant SPNs using
direct drawing was 92%, 89%, 79%, 92% and 88%, respectively. 
Conclusion: The CAD system was a useful tool for diagnosing malignant
SPNs.
olitary pulmonary nodules (SPNs) are a major concern not only for
radiologists, but also for clinicians because 30-80% of resected SPNs are
found to be malignant (1-6). The role of the radiologist for evaluating
SPNs is to accurately distinguish between benign and malignant lesions. In general, CT
has high specificity and acceptable sensitivity and accuracy, and it might be a reason-
able modality for characterizing nodules (1-11). Malignant nodules tend to enhance
substantially more than benign nodules even though some overlap, such as for active
granulomas or benign vascular tumors, has been found (2, 4, 5, 7, 12-14). More
recently, several authors have attempted to assess the washout characteristics of SPNs
on contrast-enhanced CT, which is also known as helical dynamic CT (HDCT) (10, 15-
17). Jeong et al. (15) evaluated solitary pulmonary nodules by analyzing the combined
wash-in and washout characteristics of dynamic contrast-enhanced multi-detector row
CT, and they reported 92% accuracy for distinguishing between benign and malignant
nodules.
However, a diagnosis of SPNs using HDCT is a difficult task for human readers
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CAD = computer-aided diagnosis
DLP = Dose Length Product
NE = net enhancement
NPV = negative predictive value
PE = peak enhancement
PPV = positive predictive value
ROI = region of interest
SPNs = solitary pulmonary nodules
TAC = time attenuation curve
Sbecause this method requires considerable time to calculate
the SPN enhancement and to draw the region of interest
(ROI) for all the enhancing nodules on the CT images.
Therefore, a computer-aided diagnosis (CAD) system has
great potential to resolve this problem. Some studies
reported that a CAD system that uses volumetric and
contrast-enhanced data has the potential to assist radiolo-
gists in differentiating solitary pulmonary nodules and
managing these patients (18-23). 
A CAD system can usually evaluate the quantitative
features of the nodule’s size, shape and attenuation. In
addition, these systems can calculate the enhancement
properties of SPNs on HDCT. This study was designed to
determine the usefulness of a CAD system for assisting
radiologists in differentiating between benign and
malignant SPN by analyzing the enhancement patterns of
SPNs on dynamic CT scans. For this study, after comparing
a CAD system with direct personal measurement of SPNs
on dynamic CT, we evaluated the accuracy of diagnosing
malignant SPNs with using a CAD system.
MATERIALS AND METHODS
Patients and CT Scanning
This study was performed retrospectively with the
approval of the ethics committee at our institution. Written
informed consent was obtained from all patients. From
November 2005 to May 2006, a total of 75 patients (50
men and 25 women, mean age, 60 years; age range, 25-79
years), who had a SPN seen on their chest radiography and
there was no satellite nodule on the targeted thin-section
CT scans (0.75 mm collimation, 0.5-second gantry rotation
time, 120 kVp, 50 mA) that were done on the SPN,
underwent dynamic chest CT with a sixteen-detector row
CT scanner (Somatom Sensation 16, Siemens, Erlangen,
Germany). The nodules were excluded if they contained
benign calcifications (diffuse, laminated, popcorn-like or
central), ground glass opacity, the SPN was less than 5 mm
and the nodules were juxtapleura/juxtavascular nodules as
seen on the thin-section CT. Patients with heart disease or
respiratory difficulties during the inspiration period of CT
were also excluded. Of the 75 patients, 35 patients were
excluded: 13 patients were lost to follow-up and 22
patients were followed up without a biopsy. Overall, a
total of 40 patients with SPNs (29 men and 11 women,
mean age, 56.3 years; age range, 25-79 years) that had
proven pathology were analyzed. The average long and
short axis diameters of the malignant SPNs were 20.6 ±
6.4 mm (12-30 mm) and 17.0 ± 6.1 mm (9-30 mm),
respectively. The average long and short axis diameters of
the benign SPNs were 16.2 ± 7.2 mm (7-30 mm) and
12.0 ± 4.9 mm (6-23 mm), respectively. Thirty-one
patients underwent a percutaneous needle biopsy and nine
patients underwent surgery that included a wedge
resection. 
Before intravenously injecting the contrast medium, a
series of images was obtained throughout the entire nodule
along the z-axis with 0.75 mm collimation (120 kVp, 170
mA, 0.5 second gantry rotation time). Thereafter, an
additional ten series (20s, 40s, 60s, 80s, 120s, 140s, 160s,
180s, 240s and 300s) of images were obtained at 20-
second intervals over a 5-minute period after injecting the
contrast medium (3 mL/sec, a total of 120 mL of Ultravist
�
300; Scherring, Berlin, Germany) with a power injector
(MCT Plus; Medrad, Pittsburgh, PA). Immediately after the
dynamic imaging, low-dose (Effective mA: 50-60 mAs,
120 kVp, 0.75 mm collimation) helical CT scans were
obtained from the lung apices to the level of the middle
pole of both kidneys for tumor staging. The image data
was reconstructed with a thickness of 2.0 mm and using a
standard algorithm. All the thin-sections and dynamic CT
data were interfaced directly to our picture archiving and
communication system (PACS, m-view
TM; Marotech,
Korea), which displayed all the image data on monitors
(four monitors, 1,536×2,048 image matrices, 8-bit
viewable gray scale and 60-foot-lambert luminescence).
Both the mediastinal (window width: 400 HU, window
level: 20 HU) and lung (window width: 1,500 HU, window
level: -700 HU) window images were viewed on the
monitor. The technical adequacy of dynamic CT fulfilled
the following criteria that were reported by previous
studies (14): no extravasated contrast medium at the
injection site, appropriate enhancement of the cardiovascu-
lar structures during the examination, no reaction to the
contrast medium that interfered with image acquisition and
satisfactory patient respiratory registration without
artifacts on the images. 
Radiation Exposure
The total organ doses of the thin-section, dynamic and
low-dose CT studies were calculated. An effective patient
dose from a chest CT examination is calculated by
multiplying the Dose Length Product (DLP) by the conver-
sion factor (25). The DLP is the CT dose index (CTDIvol)
multiplied by the scanned length. To establish an effective
dose for an examination from the DLP, the conversion
factors that are used are age, the scanned region, and
specific CT geometry. Generally, the conversion factor for
adult patients undergoing chest CT examinations is 0.017
mSv per mGy cm. The average calculated mean effective
dose was 15.7± 3.5 mSv (effective dose range: 9.1-19.6
mSv) in our study. The measured organ dose was
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(collimation of 1.5 mm, a slice thickeness of 5 mm, a pitch
of 1.5, 0.5 second rotation time, 120 kVp, 200 mA) at our
institution (17). The exposed radiation dose on HDCT was
30-40 mGy and the dose with performing standard
thoracic helical CT was 15-20 mGy, which is similar to
that reported elsewhere (15).
Evaluation of Enhancement Dynamics
The attenuation value of the nodule was measured on all
the images at each time (from the unenhanced image to
image acquired at 300 seconds) except for two sections
(the upper most and lowest) and the maximum diameter of
the SPN was obtained. An ROI covering approximately
the full diameter of the nodule, but excluding calcified,
cystic or necrotic areas was examined (Fig. 1). The edges of
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Fig. 1. Methods of enhancement pattern
analysis using CAD system.
A. Before intravenously injecting
contrast medium, series of images was
obtained throughout entire nodule along
z-axis, and additional ten sets (20s, 40s,
60s, 80s, 120s, 140s, 160s, 180s, 240s
and 300s) of images were obtained at
20-second intervals over 5-minute
period after injecting contrast medium.
Region of interest covered approxi-
mately full diameter of nodule and single
radiologist directly drew region of
interest. 
B. Solitary pulmonary nodule was region
of interest drawn by expert technician
with using CAD system. 
A
Bthe nodule were avoided in order to prevent partial
volume averaging. All the measurements in Hounsfield
units were obtained from the mediastinal window images
to minimize partial volume averaging. All the measure-
ments were obtained at the time of the CT examination
without the radiologist having knowledge of the histologic
diagnosis. One radiologist (prospective) with seven years
experience of directly drawing ROIs and one technician
(retrospective) with 20 years experience with chest CT and
using a CAD system (Lung care, Sensation 16, Siemens,
Germany) measured the attenuation values of the SPNs.
For each image in which a nodule appeared, an ROI was
identified by a well trained technician and using a semi-
automated procedure in order to get the best possible
segmentation. The technician initiated the ROI generation
by selecting a point within the nodule. For all nodules, the
ROIs were created, reviewed and edited by a well trained
technician and once they were found to be satisfactory, the
ROIs were approved by the thoracic radiologist (Fig. 1).
The attenuation value of the nodule obtained from the ROI
was obtained by averaging the measured values in all
section. The enhancement of the SPN was evaluated
according to the peak enhancement (PE), the net enhance-
ment (NE) and the time attenuation curve (TAC) on the
dynamic CT. The PE was defined as the maximum attenua-
tion value of the nodule over the entire duration of the
dynamic study. The NE was calculated by subtracting the
pre-enhancement attenuation from the PE attenuation. In
this study, the TAC was classified into two types, that is,
benign and malignant. The benign patterns included persis-
tent enhancement < 15 HU and no wash-out or < 25 HU
wash-out. The malignant patterns included early enhance-
ment > 15 HU and early wash-out of 5-25 HU. 
Data and Statistical Analysis
Statistical analyses were performed by using SPSS 9.0
software (SPSS Inc., Chicago, IL). The diagnostic charac-
teristics such as sensitivity, specificity, accuracy, positive
predictive value (PPV) and negative predictive value
(NPV) were calculated retrospectively by considering the
NE that signified a positive test (malignant with 15 HU or
more of NE as a cutoff) for a dynamic CT. Additionally,
the diagnostic characteristics were calculated by consider-
ing the TAC that signified a positive test (malignant with
early enhancement > 15 HU and early wash-out of 5-31
HU) on a dynamic CT scan. Fisher’s exact test and paired
t-tests were used to analyze statistically significant differ-
ences between the malignant and benign nodules.
Moreover, this study used Bland and Altman plots (26) to
compare the numerical values of enhancement (PE and
NE) between using CAD systems and those obtained by
direct personal drawing. Having calculated the mean
difference and the 95% limits of agreement, the investiga-
tors determined if the methods were sufficiently in
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Fig. 2. Bland and Altman plot showing difference between using CAD system and direct personal drawing. 
A. Difference in peak enhancement between using CAD system and direct personal drawing. 
B. Difference in net enhancement between using CAD system and direct personal drawing. X-axis represented average values of using
CAD system and direct personal drawing while y-axis represented difference in peak enhancement and net enhancement between using
CAD system and direct personal drawing. Dashed lines represent mean value of two measurements and lines above and below it
represent 95% limits of agreement. Peak enhancement was out of 95% limits of agreement only in one case, while net enhancement
was out of 95% limits of agreement in two cases. 
ABagreement for the new method to be used as an alterna-
tive. 
RESULTS
There were 13 malignant SPNs and 27 benign SPNs. The
malignant SPNs consisted of the following: adenocarci-
noma (n = 8), squamous cell carcinoma (n = 2), bronchi-
oloalveolar cell carcinoma (n = 1), mucoepidermoid
carcinoma (n = 1) and carcinoid tumor (n = 1). The benign
SPNs were tuberculosis (n = 9), focal bronchopneumonia
(n = 7), hamartoma (n = 5), fungal infection (n = 2),
intrapulmonary lymph node (n = 1), fibrotic nodule (n = 2)
and sclerosing hemangioma (n = 1). Thirty SPNs included
no calcification and 10 included puntated calcification.
Higher PE and NE were observed by direct personal
drawing and by using the CAD system (Table 1). As seen
from the numerical value of the enhancement of the PE
and NE, direct personal drawing showed higher enhance-
ment than did the CAD system. There were differences
(mean: 34.9 HU; 95% CI: 28.0-41.8) between the PE
using CAD systems (mean: 67.2 ± 27.1 HU) and the PE
using the direct personal drawing (mean: 32.3 ± 28.1
HU). In addition, there were differences (mean: 6.9 HU,
95% CI: 1.1-12.7) between the NE using the CAD systems
(mean: 25.9 ± 27.4 HU) and the NE using direct personal
drawing (mean: 32.8 ± 24.9 HU). On the other hand, as
found from the enhancement patterns of PE and NE, the
Bland and Altman plot showed that the mean difference
was 95% of the individual differences ± 2 standard
deriation (SD) (Fig. 2). With 15 HU or more of NE as a
cutoff value for differentiating malignant and benign
nodules, the sensitivity for the diagnosis of malignant SPNs
using the CAD system was 92% (12/13), the specificity
was 52% (14/27), the PPV was 48% (12/25), the NPV was
93% (14/15) and the accuracy was 65% (26/40), respec-
tively. However, the sensitivity, specificity, PPV, NPV and
the accuracy obtained by direct personal drawing of
malignant SPNs was 100% (13/13), 37% (10/27), 43%
(13/30), 100% (10/10), and 58% (23/40), respectively
(Table 2). 
On the other hand, of the 27 benign nodules, the CAD
system and direct personal drawing of 25 nodules (92.6%)
showed a similar TAC (Fig. 3). Of the 13 malignant
nodules, the CAD system and direct personal drawing of
10 nodules (83.3%) showed a similar TAC (Fig. 4). The
sensitivity, specificity, PPV, NPV and accuracy obtained
by the TAC of the malignant SPNs and using CAD was
92% (12/13), 85% (23/27), 75% (12/16), 96% (23/24)
and 88% (35/40), respectively. The sensitivity, specificity,
PPV, NPV and accuracy obtained by the TAC of the
malignant SPNs and using direct drawing was 92%
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Table 1. Comparison of Peak Enhancement and Net Enhancement for Evaluating Solitary Pulmonary
Nodules with Direct Personal Drawing and CAD System on Helical Dynamic CT
Characteristic Mean ±SD (HU) Median (HU) 95% Confidence Interval
PE
Manual  67.2±27.1 65.6 58.8-75.6
CAD  32.3±28.1 32.7 23.6-41.0
Difference  34.9±22.2 30.7 28.0-41.8
NE
Manual  32.8±24.9 28.7 25.1-40.5
CAD  25.9±27.4 24.4 17.4-34.4
Difference  06.9±18.7 07.1 01.1-12.7
Note.─ Differences of PE and NE were calculated by subtracting PE and NE, with using CAD system, from 
manual PE and NE. CAD = computer-aided diagnosis, PE = peak enhancement, NE = net enhancement, SD = standard deviation.
Table 2. Comparison of Consistency of Various Parameters between CAD System and Direct Drawing of Regions of Interest on
Helical Dynamic CT
Parameter Accuracy (%) Sensitivity (%)  Specificity (%) PPV (%) NPV (%)
NE (DR) 57.5 100 37.0 43.3 100
NE (CAD) 65.0 92.3 51.9 48.0 93.3
TAC (DR) 88.0 92.3 88.9 78.6 92.3
TAC (CAD) 88.0 92.3 85.2 75.0 96.0
Note.─ * We used to Fisher’s exact test. NE = net enhancement, TAC = time attenuation curve, DR = direct drawing, CAD = computer-aided diagnosis, 
PPV = positive predictive value, NPV = negative predictive value (12/13), 89% (24/27), 79% (14/16), 92% (24/26) and
88% (35/40), respectively. 
DISCUSSION
In this study, the analysis of the TAC using the CAD
system and the results of the direct personal drawing
produced good results for making the diagnosis of
malignant SPNs on HDCT, as compared with the using the
PE and NE. The increase in attenuation of an SPN after
contrast media injection, that is, the PE and NE, depends
on the blood supply and the volume of the extravascular
fluid in the SPN. However, the TACs of the SPNs
represented differences in vascularity, the volume of
extracellular fluid and the diffuse spread of contrast media.
More contrast medium is delivered in malignant SPNs and
the diffusion is faster compared with those of benign SPNs.
For that reason, for better diagnostic accuracy of SPNs, the
assessment of SPNs should be performed during the wash-
out of contrast medium through the SPN in addition to the
wash-in, the so called TAC. The TAC analyses using the
CAD system showed similar specificity and accuracy to
that of direct personal drawing. Therefore, the use of the
CAD system for HDCT images to evaluate the TAC
should help the thoracic radiologist differentiate between
benign and malignant SPNs by reducing the time to
calculate the SPN enhancement via negating the require-
ment to draw the ROIs for all the enhancing nodules on the
CT images (1, 6-7, 10, 15).
Swenson et al. (14) reported that cutoff values of 15 HU
produced a sensitivity of 98%, a specificity of 58% and an
accuracy of 77% for malignant nodules. Since then, the
cutoff value for diagnosing malignant nodules had been set
at 15 HU. However, Jeong et al. (15) reported that when
the diagnostic criteria for malignancy of both a wash-in
phase of 25 HU or greater and a washout phase of 5-31
HU were applied, the sensitivity, specificity and accuracy
for malignancy were 94%, 90% and 92%, respectively.
Higher PE was obtained in the malignant SPNs for which
multi-detector row CT (MDCT) was used, and thus, higher
attenuation values could be used as cutoff values for this
differentiation. For differentiating malignant and benign
nodules in our study, the cutoff value of the enhancing
SPNs was determined to be 15 HU because the PE with
using CAD was lower than that of direct personal drawing
in spite of performing MDCT. We thought that the cutoff
value to evaluate malignant SPNs could change according
to the type of CT scan that’s used or the type of measure-
ment that is used for the SPNs. 
In the past decade, many studies have reported that
CAD systems can help the radiologist detect SPNs on CT
images (18-24). Das et al. (12) reported that the radiolo-
gists’ performance in interpreting the multi-detector row
CT scans can be improved using CAD systems. They
compared the effect of two CAD systems, the Image
Checker CT (R2 Technologies, Sunnyvale, CA) and the
Nodule Enhanced Viewing (NEV) (Siemens Medical
Solutions, Forchheim, Germany) for the detection of SPN.
Regardless of the type of CAD system used, they showed
that the CAD system might provide a more accurate
diagnosis of SPNs. Lee et al. (21) showed that the sensitivi-
ties of the CAD system for detecting nodules < 5 mm in
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Fig. 3. CT scan of a benign solitary pulmonary nodule with
enhancement (≥15 HU wash-in, ≥25 HU washout) in 43-year-
old female diagnosed with sclerosing hemangioma by open lung
biopsy. Time attenuation curve obtained through nodule for 5
minutes showed similar enhancement patterns of CAD system
(short line) and direct personal drawing (long line).
Fig. 4. CT scan of adenocarcinoma with enhancement (≥15 HU
wash-in, 5-25 HU washout) in 72-year-old man. Time attenuation
curve obtained through nodule for 5 minutes showed similar
enhancement patterns of CAD system (short line) and direct
personal drawing (long line).diameter were higher than those of a radiologist. They
suggested that the CAD system can help a radiologist
detect nodules. Kim et al. (22) showed that a CAD system
may help improve the detection of nodules with ground-
glass opacity or localized ground-glass opacity. However,
most studies have focused on the size of the SPN and not
the SPN’s enhancement. In this study, the TAC using the
CAD system showed better results for diagnosing a
malignant SPN than visually evaluating the PE and NE. It
is well known that the hemodynamic differences are signif-
icant because malignant nodules tend to be more enhanced
than benign nodules. There have been some studies
designed to evaluate using the enhancement pattern of the
HDCT images for diagnosing SPNs with employing a CAD
system. For this approach, some studies used a number of
parameters to evaluate the SPNs with employing a CAD
system, e.g., the volumetric size, shape, enhancement etc
(12, 18-20). Shah et al. (18) have recently used parameters
such as the mean HU value, the median, mode and mean
of the 32 highest HU values in the ROI etc. The major
difficulty with this approach is that the analysis is limited to
a single slice and the analysis was restricted to only the
two-dimensional features. Therefore, in that study, the
reviewing radiologist identified the most visually represen-
tative slice of the nodule and he drew the ROIs of the
SPNs, while this experiment was performed helically
through the entire nodule. This could result in a difference
in diagnostic accuracy between the CAD system and the
radiologist’s direct drawing.
This study evaluated the enhancement patterns of HDCT
images with using a CAD system. In general, direct
personal drawing tended to show higher enhancement than
did the CAD system because the radiologist tried to
perform direct drawing within the SPN as much as
possible, but the CAD system included lung parenchyma
for detecting a SPN when calculating the enhancement’s
properties. As seen from the numerical value of the
enhancement of the PE and NE, it seems that there is a
difference between CAD system and direct personal
drawing. On the other hand, the Bland-Altman plot
showed that the analyses of the PE and the NE using the
CAD system produced similar results to those obtained
with direct personal drawing. Moreover, there was
uniform variability throughout the range of measurements.
Some studies showed that the sensitivity and specificity of
a CAD system were lower than those of direct personal
drawing because those studies used the morphologic
character rather than the enhancement pattern of the SPN
(18-20, 23, 24). But our study used the enhancement
pattern of HDCT images with using the CAD system to
evaluate the SPNs. Therefore, unlike the previous studies,
this study showed that the accuracy and specificity of a
CAD system was similar with that of direct personal
drawing.
Although the CAD system is a useful tool for improving
the radiologist’s performance, the CAD system has a major
drawback in that the SPN cannot be differentiated from
small peripheral vessels, most commonly branch points,
scarring or other parenchymal heterogeneities. Therefore,
if the SPN is a juxtavascular nodule, then the CAD system
might calculate the enhancement pattern of both the SPN
and it vascular component. In the case of a small sized
SPN, it is difficult to calculate the enhancement pattern of
the SPN with using a CAD system. This might produce a
false enhancement pattern of the SPN. According, we
excluded those cases in this study.
There were some limitations in the study. First, there was
an insufficient the number of cases (n = 40). Therefore,
before any type of clinical use could be considered, this
proposed method will need to be validated on a larger
dataset, i.e., more cases will be needed to test for general-
ity. Accordingly, examination of more nodules of various
sizes and shapes by CT will be needed for additional
training and testing. Second, although the variability in the
ROIs of interest is substantial between radiologists, this
was not evaluated in our study. The inadequate placement
of the ROIs of interest on nodules might result in
erroneous attenuation values, which can cause false wash-
in and washout enhancement calculations. Third, 5-
minutes was chosen as the length for the delay as a rule of
thumb, which we believe is sufficient for the washout of
the contrast material from a pulmonary nodule. Jeong et
al. (1) reported that the mean time to PE in most malignant
nodules was 3.2 minutes. In addition Yi et al. (10) reported
that most SPNs reached the peak level of enhancement
within 3 minutes. They reported that with images acquired
during 5 minutes or more, the washout dynamics of the
pulmonary nodule enhancement could be obtained.
Therefore, 5 minutes was chosen as the length for the
delay because the PE and NE were calculated and the
pattern of the TAC differentiated between the malignant
nodules and the benign nodules. In addition, there was no
attempt to standardize the injection rate and the volume of
contrast material according to the cardiac output of each
patient nor was there any attempt to standardize the
volume of contrast material according to the patients’
weight. Moreover, the calculated dose at all sites of the
nodule is not same due to a direct influence of the
radiation dose, such as the X-ray beam energy, the tube
current, rotation of exposure time, the section thickness,
the object’s thickness of attenuation, pitch, the sites of
nodule etc. Therefore, for the larger patient, the exit
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through more tissue (27). The calculated dose at all sites of
the nodules in this study was 30-40 mGy and this result
was similar to the calculated dose of other reports (1, 10). 
Despite these limitations, the results obtained from the
enhancement pattern of the SPNs using the CAD system
were similar to those obtained by the direct personal
drawing of SPNs. Consequently, the CAD system was a
useful tool for diagnosing malignant solitary pulmonary
nodules. Also, in view of the good diagnostic results for a
malignant SPN, a TAC may be more useful than the PE or
NE. 
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